{"schema_version": 1, "id": "longview-tx-msa/life-sciences/2026-10", "product": "Labor Market Pulse", "metro": {"geography_id": 287, "label": "Longview, TX MSA", "slug": "longview-tx-msa"}, "focus_area": {"key": "life_sciences", "slug": "life-sciences", "label": "Life Sciences"}, "period": "2026-10", "public_after": "2026-10-01", "frozen_at": "2026-11-03T04:24:27.100626+00:00", "headline": "Longview life sci pay diverges from a tightening state market.", "headline_summary": "Longview unemployment eased to 4.6% even as statewide biopharma postings jumped 53% year-over-year, while local Regulatory Affairs pay fell to $95,473 against a national shortage of regulatory talent.", "key_indicators": [{"label": "Longview MSA unemployment", "value": "4.6%", "context": "Down from 5.0% in August; vs 4.2% national"}, {"label": "Metro employment growth", "value": "+600 jobs YoY", "context": "124.7k total nonfarm jobs, Sept 2026"}, {"label": "Texas biopharma postings growth", "value": "+53% YoY", "context": "Jan-Aug 2026, outpacing local hiring capacity"}, {"label": "National biopharma layoffs", "value": "-90% YoY", "context": "Q3 2026, signals hiring momentum returning"}], "takeaways": [{"headline": "Biostatistician pay here is outrunning the national rate.", "body": "Metro median of $139,166 sits above the national $131,958, a reversal from most Longview life sci roles. That premium may reflect scarcity, worth confirming before assuming it signals broader market heat."}, {"headline": "Regulatory Affairs compensation is softening against a tightening national market.", "body": "Metro and national Regulatory Affairs Specialist pay both declined this month even as national commentary flags regulatory talent as the hardest life sci role to fill in 2026. A local pullback in advertised pay during a national shortage may understate the retention risk building beneath the surface."}, {"headline": "Local job growth near zero complicates the build-versus-outsource math.", "body": "With only 600 net jobs added locally over the year against a 53% statewide surge in biopharma postings, Longview employers face a shrinking local bench for specialized hires. That imbalance strengthens the case for CRO or CDMO partnerships on roles where in-market sourcing already looks constrained."}, {"headline": "Validation Engineer demand is rising while national pay holds flat.", "body": "Metro pay moved up moderately to $104,143, converging toward the $106,478 national figure. Convergence suggests Longview employers are closing a compensation gap that previously limited competitiveness for manufacturing and quality talent."}], "local_conditions": "Longview MSA unemployment eased to 4.6% in September from 5.0% in August, with nonfarm employment at 124.7 thousand \u2014 up only 600 positions year-over-year, pointing to a labor market stabilizing but not expanding meaningfully. Statewide, Texas biopharma job postings surged 53% year-over-year through August while national lab and R&D vacancy rates hit 23.2% in top markets, suggesting Longview employers compete against a state-level talent pull far outpacing local job growth.", "implications": "Flat local headcount growth alongside statewide biopharma posting surges means Longview-based R&D and quality roles likely draw candidates toward Houston, Austin, or Dallas postings offering deeper talent pools and higher advertised pay \u2014 a dynamic reinforced by Research Scientist pay sitting $7,269 below the national median locally. With national quit rates at just 1.9% and nearly a quarter of the life sciences workforce aged 55 or older, losing a single credentialed specialist in regulatory affairs or clinical operations carries outsized replacement risk in a market this thin. Consider evaluating succession coverage for scientific and quality leadership roles now, before a departure forces a build-versus-outsource decision under time pressure.", "looking_ahead": [{"category": "Early indicator", "body": "Watch whether Longview's modest unemployment decline (5.0% to 4.6%) continues through October data releases in mid-November. A reversal would tighten an already thin local labor supply for quality and manufacturing roles."}, {"category": "Emerging pressure point", "body": "Texas biopharma postings are up 53% year-over-year statewide while Longview employment barely moved. Track whether Dallas, Houston, or Austin compensation increases begin pulling credentialed Longview talent toward larger metros."}, {"category": "Worth watching", "body": "Regulatory Affairs pay fell both locally and nationally this month despite national reports citing regulatory talent as the toughest hire of 2026. A further decline alongside persistent vacancy reports would signal a disconnect between advertised pay and actual hiring difficulty."}, {"category": "Potential inflection point", "body": "National biopharma layoffs are down 90% year-over-year and M&A activity is up 63% in H1 2026, conditions that typically precede headcount expansion. Monitor whether Longview-based employers begin posting more clinical or manufacturing roles as consolidation activity plays out regionally."}], "roles": [{"role": "Research Scientist", "data_scope": "state_rollup", "metro_p25": 82764.5, "metro_p50": 123070.0, "metro_p75": 131979.0, "metro_trend_direction": "up", "metro_trend_magnitude": "significant", "national_p50": 130339.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Clinical Research Associate", "data_scope": "state_rollup", "metro_p25": 57977.0, "metro_p50": 78893.0, "metro_p75": 95462.0, "metro_trend_direction": "up", "metro_trend_magnitude": "moderate", "national_p50": 90065.0, "national_trend_direction": "up", "national_trend_magnitude": "significant"}, {"role": "Lab Technician", "data_scope": "state_rollup", "metro_p25": 38082.0, "metro_p50": 45670.0, "metro_p75": 49587.5, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 47840.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Regulatory Affairs Specialist", "data_scope": "state_rollup", "metro_p25": 70793.0, "metro_p50": 95472.6, "metro_p75": 116373.0, "metro_trend_direction": "down", "metro_trend_magnitude": "moderate", "national_p50": 103779.6, "national_trend_direction": "down", "national_trend_magnitude": "moderate"}, {"role": "Clinical Data Manager", "data_scope": "state_rollup", "metro_p25": 96453.0, "metro_p50": 122953.0, "metro_p75": 135700.0, "metro_trend_direction": "stable", "metro_trend_magnitude": "stable", "national_p50": 123653.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Biostatistician", "data_scope": "state_rollup", "metro_p25": 98484.75, "metro_p50": 139166.0, "metro_p75": 160691.25, "metro_trend_direction": "up", "metro_trend_magnitude": "moderate", "national_p50": 131958.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}, {"role": "Validation Engineer", "data_scope": "state_rollup", "metro_p25": 82756.0, "metro_p50": 104143.2, "metro_p75": 112977.0, "metro_trend_direction": "up", "metro_trend_magnitude": "moderate", "national_p50": 106478.0, "national_trend_direction": "stable", "national_trend_magnitude": "stable"}], "industry_snapshot": [], "citations": [{"source_name": "Texas Workforce Commission", "source_url": null, "statement": "Longview MSA unemployment rate and nonfarm employment figures for September 2026"}, {"source_name": "Texas life sciences labor market research", "source_url": null, "statement": "Texas biopharma job postings surged 53% YoY Jan-Aug 2026"}, {"source_name": "Biopharma industry labor market survey", "source_url": null, "statement": "National quit rate at 1.9% and life sciences workforce aging data"}, {"source_name": "National life sciences labor market research", "source_url": null, "statement": "Regulatory affairs cited as hardest-to-fill pharma role in 2026"}, {"source_name": "Biopharma industry labor market research", "source_url": null, "statement": "National biopharma layoffs down 90% YoY, M&A activity up 63% H1 2026"}, {"source_name": "Life sciences labor market research", "source_url": null, "statement": "Lab/R&D vacancy reached 23.2% across top 13 U.S. life sciences markets Q1 2026"}], "methodology": "Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay.", "edition_label": "November 2026", "files": {"html": "longview-tx-msa/life-sciences/2026-10.html", "pdf": "longview-tx-msa/life-sciences/2026-10.pdf"}, "published_at": "2026-11-03T08:25:15.964580+00:00", "report_html_url": "https://reports.wagescape.com/archive/v1/editions/longview-tx-msa/life-sciences/2026-10.html", "report_pdf_url": "https://reports.wagescape.com/archive/v1/editions/longview-tx-msa/life-sciences/2026-10.pdf"}